Senate designates cholesterol awareness month to address heart disease disparities

What it does

This resolution designates September 2025 as 'National Cholesterol Education Month' and September 30, 2025, as 'LDL-C Awareness Day' to encourage Americans to know their cholesterol levels and raise awareness about cardiovascular disease prevention. The resolution highlights that elevated LDL cholesterol is a modifiable risk factor for heart disease and stroke, notes disparities in screening and treatment (particularly among African Americans and rural populations), and calls for improved access to cholesterol testing and treatment.

Why we flagged it

This is a straightforward commemorative resolution promoting cardiovascular disease awareness and cholesterol screening. It contains no legislative mechanism, appropriations, or regulatory change—only a designation and encouragement for public health action.

What the text implies

• The resolution's emphasis on screening gaps and disparities (e.g., only 27% of post-heart-attack patients receive LDL-C tests within 90 days; African Americans screened at lower rates) may indirectly pressure healthcare systems and payers to improve access and testing protocols.
• By highlighting that 71% of high-risk hypercholesterolemia patients do not achieve treatment guideline thresholds, the resolution creates a public record of undertreatment that could inform future policy or regulatory action on lipid-lowering therapy access.

Who stands to gain

pharmaceutical companies (statin and lipid-lowering therapy manufacturers); clinical laboratory and diagnostic testing providers; healthcare systems and cardiology practices